By Swapan Das, Calcutta
In 1950, a group of physicians researching “Tissue Therapy” got together and established the “Tissue Therapy Research Institute”. After developing Placenta Extract injections in 1956 they founded “Melsmon Pharmaceutical Company Limited which obtained government approval and began manufacture and sale of Melsmon injection as a treatment for menopausal, disorders and failed lactations.
The website of Melsmon claims:
Melsmon Cell Revitalization Extract has been highly accepted by the medical society in Japan. Melsmon is listed on the Nippon Health Insurance drug tariff (NHI). As an approved pharmaceutical product listed on the NHI drug tariff, the Japanese Government actually pays for suitable Japanese citizens to use Melsmon.The readers may refer the following links to know more about this product and the manufacturer:
- Official Website of Melsmon
- Japanese Govt. Approval
- Dr Kentaro Yoshida (Japan) on Human Placental Extract & Melsmon